This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.

Medicines safety

The Medicines Safety Improvement Programme (MedSIP) forms one of the core elements of the NHS Patient Safety Strategy, 2019. Its overarching aim is to reduce medication-related harm in health and social care, focusing on high-risk drugs, situations and vulnerable patients. The programme will contribute to the WHO Challenge target (2017) to reduce severe avoidable medication-related harm globally by 50% over five years. Nationally, three quality improvement priorities have been chosen. Read more >

  • Overview

    Find out more about medicines safety priorities

  • Care homes

    How we’re improving medicines safety

  • Contact us

    Email our Patient Safety Manager, Geri Briggs